–
Nurix Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−118
FY22:
−184
FY23:
−155
FY24:
−213
FY25:
−286
(positive)
Change from FY21 to FY25
millions USD
FY21:
−112
FY22:
−173
FY23:
−141
FY24:
−197
FY25:
−267
(positive)
Change from FY21 to FY25
millions USD
FY21:
−117
FY22:
−180
FY23:
−144
FY24:
−193
FY25:
−264
(positive)
Change from FY21 to FY25
millions USD
FY21:
−117
FY22:
−180
FY23:
−144
FY24:
−194
FY25:
−264
All amounts in millions USD